BillionToOne

BillionToOne P/TBV

The Price to Tangible Book Value (P/TBV) of BillionToOne (BLLN) as of Oct 15, 2026 is 8.45. In the previous year, Price to Tangible Book Value (P/TBV) was 24.18 — a change of -65.06% (lower).

P/TBV

8.45

YoY

-65.06%

Last updated:

Price to Tangible Book Value (P/TBV) of BillionToOne is 2025 8.45 . Price to Tangible Book Value (P/TBV) of BillionToOne was 2024 24.18 . It decreases by -65.06% lower compared to the previous year.

The BillionToOne P/TBV history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/TBV
Date
P/TBV
Jan 1, 2023
133.08 USD
Jan 1, 2024
24.18 USD
Jan 1, 2025
8.45 USD
The BillionToOne P/TBV history
YEARP/TBVYoY
8.45-65.06%
24.18-81.83%
133.08—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

BillionToOne Stock analysis

What does BillionToOne do? BillionToOne Inc, a US-based company headquartered in Menlo Park, California, operates within the Health Care sector. The company is scheduled to go public on November 6, 2025, with the ticker symbol BLLN and ISIN US0901681058. BillionToOne Inc is described as a precision diagnostics company focused on innovative molecular counter technology. The company's Quantitative Counting Template (QCT) platform is noted for its ability to count DNA molecules at the single-count level, enabling the detection of risks associated with common and severe genetic diseases. The company's product UNITY is a noninvasive prenatal screening test that analyzes fetal cell-free DNA in a maternal blood sample to screen for cystic fibrosis (CF) and spinal muscular atrophy (SMA). The product is designed to provide diagnostic insights without invasive procedures, leveraging the QCT platform's unique counting capabilities. The company's website is https://www.billiontoone.com/. As of the provided information, no additional details about the company's founding year, key personnel, acquisitions, or specific financial figures are available. The company's focus remains on advancing precision diagnostics through its proprietary technology, targeting genetic disease risk assessment in prenatal care. BillionToOne is one of the most popular companies on Eulerpool.

Frequently Asked Questions about BillionToOne stock

Price to Tangible Book Value (P/TBV) of BillionToOne is 8.45 in 2025.

Price to Tangible Book Value (P/TBV) of BillionToOne changed from 24.18 to 8.45, representing a -65.06% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Price to Tangible Book Value (P/TBV) BillionToOne since 2006 – with annual values, charts, and detailed analysis.

P/TBV compares the stock price to tangible book value per share, excluding goodwill and intangibles. It provides a conservative asset-based valuation.

To evaluate Price to Tangible Book Value (P/TBV)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Price to Tangible Book Value (P/TBV).

A 'good' varies by industry and company stage. On Eulerpool, you can compare Price to Tangible Book Value (P/TBV)'s BillionToOne with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — BillionToOne

All Key Metrics — BillionToOne